EN DE
STOCK COMPARISON

Curatis N vs Merck KGaA: Fair Value & Quality

Both stocks run through our valuation models. Here is how Curatis N (CURN) and Merck KGaA (MRK) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Curatis N trades at CHF 18.90 versus a fair value of CHF 4.95 (-74%), while Merck KGaA trades at €134 versus €109 (-19%).
Curatis N
CURN.SW · CHF · Financials
-74%
upside to fair value
overvalued
PriceCHF 18.90
Fair ValueCHF 4.95
Quality32/100
Merck KGaA
MRK.XETRA · EUR · Health Care
-19%
upside to fair value
overvalued
Price€134
Fair Value€109
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Curatis NMerck KGaA
Valuation
n/aP/E (TTM)24.1×
13.50×P/S (TTM)3.16×
3.16× · book value is mostly goodwillP/B2.32×
n/aEV/EBITDA13.0×
n/aPEG2.76×
−73.8%Fair value upside−18.9%
n/aDividend yield1.6%
n/aDividend per share€2.20
Profitability
-5%Operating margin18%
n/aEBIT margin trend (5Y)1.07×
-3%Return on equity9%
-2%Return on assets5%
Growth
13%Revenue growth (YoY)-3%
n/aAvg. growth/yr (3Y)-1.7%
21.3%Avg. growth/yr (5Y)3.8%
n/aValue creation/yr+7.2%
Balance & size
n/aInterest coverage (EBIT/interest)15.5×
n/aDebt / equity0.36×
$146MMarket cap$66B
mixedGrowth qualitymixed
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Merck KGaA leads: 1 to 3 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Curatis Nof which business quality 32 · market factors 47 Merck KGaAof which business quality 61 · market factors 66
ProfitabilityMargins and returns on capital today
6
41
Quality GrowthAre margins and returns improving?
94
40
CashflowEarnings quality: real cash, not paper profit
9
57
Fin. StrengthBalance sheet, leverage, solvency risk
70
76
InvestmentDisciplined investing over empire-building
16
80
Low VolatilityCalm price path (market factor)
50
72
MomentumPrice trend over the last 3–12 months (market factor)
37
61
52W MomentumDistance to the 52-week high (market factor)
59
68
Net IssuanceShare count: buybacks or dilution?
0
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyCuratis NPrice CHF 18.90Merck KGaAPrice €134
DCF Modelsn/a-20%below the price€107
Earnings-Basedn/a-60%below the price€53.25
Dividend Discountn/a-70%below the price€40.71
Multiplesn/a-12%close to the price€118
Asset-Based-69%below the priceCHF 5.82-67%below the price€44.06
Growth DCFn/a-29%below the price€94.57
Economic Profitn/a-50%below the price€66.44
Growth Earningsn/a-14%close to the price€115
Minimum-69%below the priceCHF 5.82-70%below the price€40.71
Maximum-69%below the priceCHF 5.82-12%close to the price€118
Median-69%below the priceCHF 5.82-40%below the price€80.50
Geometric mean-69%below the priceCHF 5.82-45%below the price€73.75

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Curatis N: 1 of 1 models see the stock below the current price.

Merck KGaA: 23 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Curatis N
Price CHF 18.90
Fair Value CHF 4.95
Bear CHF 3.70Bull CHF 7.39
Merck KGaA
Price €134
Fair Value €109
Bear €59.91Bull €150

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Curatis N · Financials

Quality score32 · bottom 25%
Fair value upside-74% · bottom 25%

Merck KGaA · Health Care

Quality score62 · above median
Fair value upside-19% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Curatis N trades at CHF 18.90 versus a fair value of CHF 4.95 (-74%), while Merck KGaA trades at €134 versus €109 (-19%).

Merck KGaA has the higher quality score (62/100).

Open Merck KGaA live analysis →
Curatis N · Merck KGaA

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Curatis N

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Merck KGaA

Microsoft vs Taiwan Semiconductor ManufacturingBroadcom vs MicrosoftMicrosoft vs Micron TechnologyAdvanced Micro Devices vs Microsoft
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.